NCT01055977已完成不适用
Statin Therapy Results in the Real World Practice in the Czech Republic
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 3,253
- 试验地点
- 1
- 主要终点
- LDL-C
研究概览
简要总结
Statins are the first choice treatment of dyslipidemia, a major contributor to cardiovascular diseases. Statins also have enough evidence to demonstrate decrease of morbidity and mortality from cardiovascular diseases. Even though statin therapy is effective treatment of dyslipidaemia not all patients reach the goal levels.
The aim of the study is to estimate proportion of patients who achieved the therapeutic goal (LDL-C. total cholesterol, HDL-C and triglycerides levels) after at least one year of a statin therapy.
研究设计
- 研究类型
- Observational
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Documented statin therapy for at least 12 months
- •Available two LDL-C values: one at the beginning of statin therapy or at the time when patient comes to a specialist; and the other one at least after 12 months of treatment. The latter value should not be older than 6 months.
排除标准
- 未提供
结局指标
主要结局
LDL-C
时间窗: one year
次要结局
- Total cholesterol(one year)
- HDL-C(one year)
- triglycerides(one year)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
4 期
Low- and Moderate-intensity Statin and Clinical Outcome of Primary Prevention in Individuals Aged >70 Years: the SCOPE-70 RCT StudyHealthy Elderly Individuals With High LDL-cholesterol or Risk of Cardiovascular DiseaseNCT03770312Yonsei University724
已完成
2 期
Trial to Evaluate the Effect of Statins on Asthma Control of Patients With Chronic AsthmaAsthmaNCT00126048University of Glasgow54
已完成
不适用
The Association of Statins on Cardiorespiratory Fitness and Exercise AdaptationStatin Adverse ReactionNCT04986241University of Sao Paulo General Hospital18,557
招募中
不适用
STREAM Trial - Subclinical AtherosclerosisStatin Treatment for Primary PreventionNCT05482399Insel Gruppe AG, University Hospital Bern500
已完成
不适用
Livalo Acute Myocardial Infarction StudyAcute Myocardial InfarctionNCT00805714JW Pharmaceutical1,128